Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Meignan

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
Haematologica|June 9, 2022
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cellsJean Galtier, Laetitia Vercellino, Loic Chartier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working GroupSally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Reply to G. Keramida et alSally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMSJehan Dupuis, Alina Berriolo-Riedinger, Anne Julian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2015
Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et alSally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Blood|February 14, 2018
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trialAnne-Ségolène Cottereau, Annibale Versari, Annika Loft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association StudyRené-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
Haematologica|May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baselineCédric Rossi, Marc André, Jehan Dupuis, et al.
Blood|December 22, 2021
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA studyEmmanuel Bachy, Roch Houot, Pierre Feugier, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
Haematologica|June 9, 2022
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cellsJean Galtier, Laetitia Vercellino, Loic Chartier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2014
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working GroupSally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Reply to G. Keramida et alSally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMSJehan Dupuis, Alina Berriolo-Riedinger, Anne Julian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2015
Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et alSally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Blood|February 14, 2018
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trialAnne-Ségolène Cottereau, Annibale Versari, Annika Loft, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association StudyRené-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
Haematologica|May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baselineCédric Rossi, Marc André, Jehan Dupuis, et al.
Blood|December 22, 2021
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA studyEmmanuel Bachy, Roch Houot, Pierre Feugier, et al.
Pageof 13